PRGO
Price
$13.84
Change
-$0.47 (-3.28%)
Updated
Sep 23 closing price
Capitalization
1.99B
48 days until earnings call
Intraday BUY SELL Signals
SUPN
Price
$43.39
Change
-$0.36 (-0.82%)
Updated
Sep 23 closing price
Capitalization
2.55B
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PRGO vs SUPN

PRGO vs SUPN Comparison Chart in %
View a ticker or compare two or three
VS
PRGO vs. SUPN commentary
Sep 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRGO is a Hold and SUPN is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
PRGO vs SUPN: Fundamental Ratings
PRGO
SUPN
OUTLOOK RATING
1..100
8557
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
69
Overvalued
PROFIT vs RISK RATING
1..100
10048
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
3970
P/E GROWTH RATING
1..100
299
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (53) in the Pharmaceuticals Other industry is in the same range as SUPN (69). This means that PRGO’s stock grew similarly to SUPN’s over the last 12 months.

SUPN's Profit vs Risk Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for PRGO (100). This means that SUPN’s stock grew somewhat faster than PRGO’s over the last 12 months.

SUPN's SMR Rating (94) in the Pharmaceuticals Other industry is in the same range as PRGO (98). This means that SUPN’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's Price Growth Rating (39) in the Pharmaceuticals Other industry is in the same range as SUPN (70). This means that PRGO’s stock grew similarly to SUPN’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is significantly better than the same rating for SUPN (99). This means that PRGO’s stock grew significantly faster than SUPN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRGOSUPN
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
62%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
64%
Advances
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
73%
Declines
ODDS (%)
Bearish Trend 8 days ago
68%
Bearish Trend 10 days ago
63%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
66%
COMPARISON
Comparison
Sep 24, 2026
Stock price -- (PRGO: $13.84 vs. SUPN: $43.39)
Brand notoriety: PRGO and SUPN are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PRGO: 53% vs. SUPN: 70%
Market capitalization -- PRGO: $1.99B vs. SUPN: $2.55B
PRGO [@Pharmaceuticals: Generic] is valued at $1.99B. SUPN’s [@Pharmaceuticals: Generic] market capitalization is $2.55B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $66.17B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRGO’s FA Score shows that 1 FA rating(s) are green while SUPN’s FA Score has 0 green FA rating(s).

  • PRGO’s FA Score: 1 green, 4 red.
  • SUPN’s FA Score: 0 green, 5 red.
According to our system of comparison, PRGO is a better buy in the long-term than SUPN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRGO’s TA Score shows that 5 TA indicator(s) are bullish while SUPN’s TA Score has 5 bullish TA indicator(s).

  • PRGO’s TA Score: 5 bullish, 4 bearish.
  • SUPN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both PRGO and SUPN are a good buy in the short-term.

Price Growth

PRGO (@Pharmaceuticals: Generic) experienced а +2.22% price change this week, while SUPN (@Pharmaceuticals: Generic) price change was +4.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.76%. For the same industry, the average monthly price growth was -5.19%, and the average quarterly price growth was +43.31%.

Reported Earning Dates

PRGO is expected to report earnings on Nov 11, 2026.

SUPN is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.76% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
PRGO
Daily Signal:
Gain/Loss:
SUPN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FCOR45.790.04
+0.10%
Fidelity Corporate Bond ETF (FCOR)
JSI50.53N/A
+0.01%
Janus Henderson Securitized Income ETF (JSI)
CVRD18.51-0.04
-0.22%
Madison Covered Call ETF (CVRD)
HWSM30.52-0.10
-0.33%
Hotchkis & Wiley SMID Cap Diversified Value Fund (HWSM)
KOLD26.55-3.14
-10.58%
ProShares UltraShort Bloomberg Natural Gas (KOLD)

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with SUPN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then SUPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-3.28%
SUPN - PRGO
49%
Loosely correlated
-0.82%
ELAN - PRGO
37%
Loosely correlated
-1.57%
EVO - PRGO
36%
Loosely correlated
-2.53%
ALVO - PRGO
34%
Loosely correlated
-0.51%
PBH - PRGO
33%
Poorly correlated
-3.79%
More

SUPN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SUPN has been loosely correlated with PRGO. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SUPN jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
-0.82%
PRGO - SUPN
48%
Loosely correlated
-3.28%
INDV - SUPN
35%
Loosely correlated
-0.77%
ANIP - SUPN
33%
Poorly correlated
-4.47%
EVO - SUPN
30%
Poorly correlated
-2.53%
ELAN - SUPN
28%
Poorly correlated
-1.57%
More